A Research Study of a New Medicine NNC0519-0130 in Japanese and Non-Japanese Men
Status:
Not yet recruiting
Trial end date:
2023-11-14
Target enrollment:
Participant gender:
Summary
NNC0519-0130 is a new medicine which may possibly help participants with type 2 diabetes.
This study, will look into how safe the new medicine NNC0519-0130 is, and we will measure its
concentrations in the blood and look at its effects. This study will last for a maximum of 19
weeks and Japanese and Non-Japanese male participants will be included.